Evidence map›Paper›PMID 42111516›Full record

ArticleThe Pan African medical journal2026

Epidemiology, clinical characteristics, and risk factors of SARS-CoV-2 in Côte d'Ivoire: a cross-sectional study.

Jacques Danho Monney, Herve Alberic Kadjo, Yakoura Karidja Ouattara, Valery Edgard Adjogoua, Daouda Coulibaly, Mireille Dosso, Meité Syndou, Karamoko Yahaya

Abstract read
In one paragraph

Article in The Pan African medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jacques Danho MonneyBiological Sciences Training and Research Unit, Animal Biology Department, Peleforo Gon Coulibaly University, Korhogo, Côte d'Ivoire.
Herve Alberic KadjoPasteur Institute, Abidjan, Côte d'Ivoire.
Yakoura Karidja OuattaraPasteur Institute, Abidjan, Côte d'Ivoire.
Valery Edgard AdjogouaPasteur Institute, Abidjan, Côte d'Ivoire.
Daouda CoulibalyNational Institute of Public Hygiene, Abidjan, Côte d'Ivoire.
Mireille DossoPasteur Institute, Abidjan, Côte d'Ivoire.
Meité SyndouPasteur Institute, Abidjan, Côte d'Ivoire.
Karamoko YahayaNature Sciences Training and Research Unit, Animal Biology and Cytology Laboratory, Nangui Abrogoua University, Abidjan, Côte d'Ivoire.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: the COVID-19 pandemic has posed significant epidemiological challenges globally, with marked regional variations in transmission, severity, and outcomes. In Côte d'Ivoire, disparities in healthcare infrastructure, testing capacity, and demographics have influenced SARS-CoV-2 infection dynamics. This study aims to describe the epidemiological and clinical characteristics of SARS-CoV-2 infection, as well as to identify the risk factors associated with the severity of the infection. Methods: a study was conducted using nasopharyngeal samples collected between January and December 2020, as part of Côte d'Ivoire's national COVID-19 response. The study included individuals from all socio-professional groups across urban and rural areas. Sampling was performed in various settings, including hospitals, testing centres, and community-based screenings. The testing was voluntary, systematic, and based on several factors, including both symptomatic and asymptomatic individuals, contacts of confirmed cases, suspected individuals, hospitalised patients, and participation in public health campaigns. All individuals who underwent testing were included without any specific selection process. The study population was generally representative of the national population, although a higher proportion of urban individuals were included due to limited testing in rural areas. SARS-CoV-2 was detected by real-time RT-PCR. Statistical analyses included chi-squared tests, logistic regression, and Multiple Correspondence Analysis (MCA) to identify factors associated with positivity, hospitalisation, and mortality. Results: the study included 240,599 individuals, with a mean age of 38 years (SD = 13.97). Of the total, 93,391 (39%) were women and 147,208 (61%) were men. The SARS-CoV-2 prevalence was 9.31% (95% CI: [0.89 - 0.97]), with higher prevalence in women (10.07%) compared to men (8.83%) (X Conclusion: this study identifies key factors influencing hospitalisation and mortality in SARS-CoV-2-positive patients. Age, cough, and gastrointestinal symptoms (diarrhoea or vomiting) were strongly associated with an increased likelihood of hospitalisation, while age and cough were significant predictors of mortality. These findings highlight the importance of early identification and monitoring of patients with these characteristics, particularly in settings with limited healthcare infrastructure.

Indexed as

COVID-19HospitalizationAdolescentAdultAgedChildChild, PreschoolCote d'IvoireCross-Sectional StudiesFemaleHumansInfantMaleMiddle AgedRisk FactorsRural Populationclinical characteristicsCôte d’IvoireCOVID-19epidemiologyrisk factorsSARS-CoV-2

Identifiers

PMID42111516
PMCPMC13156017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.